Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04060 | 33773192 | Phytomedicine | Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. | 2021 | Details |
| A04061 | 33772908 | Biofactors | The role of biofactors in the prevention and treatment of age-related diseases. | 2021 | Details |
| A04062 | 33772833 | Hepatology | Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. | 2021 | Details |
| A04063 | 33772456 | Indian J Gastroenterol | Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study. | 2021 | Details |
| A04064 | 33772116 | Commun Biol | INPP4B protects from metabolic syndrome and associated disorders. | 2021 | Details |
| A04065 | 33771967 | Cell Death Dis | E3 ubiquitin ligase Grail promotes hepatic steatosis through Sirt1 inhibition. | 2021 | Details |
| A04066 | 33771899 | Cancer Res | E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment. | 2021 | Details |
| A04067 | 33771728 | Mol Metab | Ube2i deletion in adipocytes causes lipoatrophy in mice. | 2021 | Details |
| A04068 | 33771699 | Pharmacol Res | Epigenetics in NAFLD/NASH: Targets and therapy. | 2021 | Details |
| A04069 | 33771638 | J Ethnopharmacol | Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. | 2021 | Details |
| A04071 | 33770523 | Mol Immunol | IFN-γ contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1β/TLR2 signaling pathway. | 2021 | Details |
| A04072 | 33769703 | Physiol Rep | ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis. | 2021 | Details |
| A04073 | 33769609 | FASEB J | CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis. | 2021 | Details |
| A04074 | 33769558 | Australas J Dermatol | Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis. | 2021 | Details |
| A04075 | 33769376 | Curr Opin Gastroenterol | The role of bariatric surgery in the management of nonalcoholic steatohepatitis. | 2021 | Details |
| A04076 | 33768700 | J Dtsch Dermatol Ges | Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network? | 2021 | Details |
| A04077 | 33768585 | Hepatology | Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation. | 2021 | Details |
| A04078 | 33768292 | Eur Radiol | Precise whole liver automatic segmentation and quantification of PDFF and R2* on MR images. | 2021 | Details |
| A04079 | 33767944 | Curr Hepatol Rep | Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04080 | 33767591 | Int J Biol Sci | Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. | 2021 | Details |
| A04081 | 33767101 | Am J Gastroenterol | Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study. | 2021 | Details |
| A04082 | 33766233 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | [Down-regulation of IL-25 accompanied by a decrease in the number of M2 macrophages in patients of non-alcoholic fatty liver disease with significant liver fibrosis]. | 2021 | Details |
| A04083 | 33766176 | Br J Nutr | 'Focus on diet quality': a qualitative study of clinicians' perspectives of use of the Mediterranean dietary pattern for non-alcoholic fatty liver disease. | 2021 | Details |
| A04084 | 33766130 | Biol Sex Differ | Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. | 2021 | Details |
| A04085 | 33766067 | Lipids Health Dis | LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. | 2021 | Details |
| A04086 | 33765931 | BMC Gastroenterol | Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand. | 2021 | Details |
| A04087 | 33765728 | Clin Endosc | Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection. | 2021 | Details |
| A04088 | 33764550 | Aliment Pharmacol Ther | Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A04089 | 33763391 | Can J Gastroenterol Hepatol | Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes. | 2021 | Details |
| A04090 | 33763324 | Cureus | Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics. | 2021 | Details |
| A04091 | 33763027 | Front Endocrinol (Lausanne) | Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. | 2021 | Details |
| A04092 | 33762835 | Diabetes Metab Syndr Obes | Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. | 2021 | Details |
| A04093 | 33762736 | Nature | Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. | 2021 | Details |
| A04094 | 33762733 | Nature | NASH limits anti-tumour surveillance in immunotherapy-treated HCC. | 2021 | Details |
| A04095 | 33762390 | Clin Med (Lond) | Hydrogen treatment: a novel option in liver diseases. | 2021 | Details |
| A04096 | 33761728 | Medicine (Baltimore) | Xiaochaihu decoction for nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis. | 2021 | Details |
| A04097 | 33761646 | Medicine (Baltimore) | The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials. | 2021 | Details |
| A04098 | 33761609 | Biomed Pharmacother | Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis. | 2021 | Details |
| A04100 | 33760189 | Mol Med Rep | Silibinin improves nonalcoholic fatty liver by regulating the expression of miR‑122: An in vitro and in vivo study. | 2021 | Details |
| A04102 | 33759300 | Diabetes Metab Res Rev | Advanced liver fibrosis and the metabolic syndrome in a primary care setting. | 2021 | Details |
| A04103 | 33759220 | Biofactors | Novel roles of Tsukushi in signaling pathways and multiple disease processes. | 2021 | Details |
| A04104 | 33757528 | Lipids Health Dis | Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A04105 | 33757144 | Z Gastroenterol | [Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data]. | 2021 | Details |
| A04106 | 33755449 | J Agric Food Chem | Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04107 | 33755196 | Eur J Clin Invest | Pattern of macrovascular invasion in hepatocellular carcinoma. | 2021 | Details |
| A04108 | 33754726 | J Proteome Res | Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease. | 2021 | Details |
| A04109 | 33754067 | Theranostics | NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. | 2021 | Details |
| A04110 | 33753727 | Cell Death Dis | S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD. | 2021 | Details |
| A04111 | 33753108 | Eur J Pharmacol | Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed rats. | 2021 | Details |
| A04112 | 33753007 | Surg Obes Relat Dis | Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats. | 2021 | Details |
| A04113 | 33752262 | FEBS Lett | Calcium transfer between endoplasmic reticulum and mitochondria in liver diseases. | 2021 | Details |
| A04114 | 33752128 | EBioMedicine | Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis. | 2021 | Details |
| A04115 | 33751907 | J Med Food | A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. | 2021 | Details |
| A04116 | 33751877 | Clin Mol Hepatol | From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? | 2021 | Details |
| A04117 | 33751456 | Curr Obes Rep | Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives. | 2021 | Details |
| A04118 | 33751289 | Eur J Health Econ | Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018. | 2021 | Details |
| A04119 | 33750841 | Sci Rep | COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. | 2021 | Details |
| A04120 | 33750416 | J Transl Med | LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[Formula: see text]B/JNK pathway by endoplasmic reticulum stress. | 2021 | Details |
| A04121 | 33749862 | J Ultrasound Med | Liver Fat Assessment in Multiview Sonography Using Transfer Learning With Convolutional Neural Networks. | 2021 | Details |
| A04123 | 33748729 | JHEP Rep | Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States. | 2021 | Details |
| A04124 | 33748727 | JHEP Rep | Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation. | 2021 | Details |
| A04125 | 33748726 | JHEP Rep | NAFLD and MAFLD as emerging causes of HCC: A populational study. | 2021 | Details |
| A04126 | 33746906 | Front Endocrinol (Lausanne) | Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. | 2021 | Details |
| A04127 | 33746771 | Front Physiol | Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver. | 2021 | Details |
| A04128 | 33746742 | Front Pharmacol | Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway. | 2021 | Details |
| A04129 | 33746450 | J Clin Exp Hepatol | Long-term Management of the Adult Liver Transplantation Recipients. | 2020 | Details |
| A04130 | 33746449 | J Clin Exp Hepatol | What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A04131 | 33746447 | J Clin Exp Hepatol | Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. | 2020 | Details |
| A04133 | 33746083 | J Hepatol | Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. | 2021 | Details |
| A04134 | 33746082 | J Hepatol | The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis. | 2021 | Details |
| A04135 | 33745998 | J Pediatr | Under-reporting of Hepatic Steatosis in Children: A Missed Opportunity for Early Detection. | 2021 | Details |
| A04136 | 33745573 | Clin Nutr ESPEN | A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older. | 2021 | Details |
| A04137 | 33744378 | Diabetes Res Clin Pract | The prevalence of metabolic associated fatty liver detected by FibroScan® in women with gestational diabetes in a multiethnic population. | 2021 | Details |
| A04138 | 33744305 | Gastroenterology | Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. | 2021 | Details |
| A04139 | 33744170 | Dig Liver Dis | Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. | 2021 | Details |
| A04140 | 33743586 | BMC Gastroenterol | Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. | 2021 | Details |
| A04141 | 33743554 | Hepatology | Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04142 | 33743323 | Nutr Res | Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis. | 2020 | Details |
| A04143 | 33743291 | Clin Nutr | U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. | 2021 | Details |
| A04145 | 33742744 | J Diabetes Investig | Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status. | 2021 | Details |
| A04146 | 33742318 | Curr Diab Rep | The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk. | 2021 | Details |
| A04147 | 33741532 | Mol Metab | TCF7 is not essential for glucose homeostasis in mice. | 2021 | Details |
| A04148 | 33741024 | Diabetol Metab Syndr | Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil. | 2021 | Details |
| A04149 | 33740939 | BMC Endocr Disord | Hemoglobin concentration is associated with the incidence of metabolic syndrome. | 2021 | Details |
| A04150 | 33740627 | Eur J Radiol | LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI? | 2021 | Details |
| A04151 | 33740211 | Hepatol Int | Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease. | 2021 | Details |
| A04152 | 33739984 | PLoS One | Association between sarcopenia level and metabolic syndrome. | 2021 | Details |
| A04153 | 33739636 | Korean J Radiol | Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. | 2021 | Details |
| A04155 | 33739030 | Clin Lab | Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis. | 2021 | Details |
| A04156 | 33736626 | BMC Endocr Disord | Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study. | 2021 | Details |
| A04157 | 33736456 | Antioxid Redox Signal | Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk. | 2021 | Details |
| A04158 | 33735936 | J Gastroenterol Hepatol | Public awareness and knowledge of liver health and diseases in Singapore. | 2021 | Details |
| A04159 | 33734012 | Autophagy | MED1 mediator subunit is a key regulator of hepatic autophagy and lipid metabolism. | 2021 | Details |
| A04160 | 33733575 | Biofactors | Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21. | 2021 | Details |
| A04161 | 33733078 | JHEP Rep | European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease? | 2021 | Details |
| A04162 | 33732887 | JGH Open | Coronary artery disease and non-alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans. | 2021 | Details |
| A04163 | 33732030 | Clin Pharmacol | Clinical Impact of Liraglutide as a Treatment of Obesity. | 2021 | Details |
| A04164 | 33731798 | Sci Rep | Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. | 2021 | Details |
| A04165 | 33731590 | Eur J Gastroenterol Hepatol | Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity. | 2021 | Details |
| A04166 | 33731579 | Eur J Gastroenterol Hepatol | Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea. | 2021 | Details |